durapatite has been researched along with Neoplasms in 41 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.44) | 18.7374 |
| 1990's | 1 (2.44) | 18.2507 |
| 2000's | 5 (12.20) | 29.6817 |
| 2010's | 18 (43.90) | 24.3611 |
| 2020's | 16 (39.02) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Z; Tian, F; Wan, W; Wang, X; Yang, J | 1 |
| Chen, J; Guan, S; Liu, S; Wang, J; Zhang, T | 1 |
| De Lama-Odría, MDC; Del Valle, LJ; Puiggalí, J | 1 |
| Anraku, Y; Ikoma, T; Nakagawa, Y; Quindoza, GM | 1 |
| Dong, X; Liu, C; Qian, J; Sun, Y; Zang, C; Zhang, S | 1 |
| Anderson, JM; Chen, S; Geng, M; Xing, Z; Yang, X; Zhang, X; Zhao, R; Zhu, X | 1 |
| da Fonseca Filho, HD; Ghegoiu, L; Liliana Iconaru, S; Matos, RS; Predoi, D; Steluţa Ciobanu, C; Ţălu, Ş | 1 |
| Li, X; Li, Z; Min, L; Tang, J; Tu, C; Wang, G; Wang, L; Wu, H; Xiao, C; Yang, X; Yu, S; Yu, Z; Zhang, K; Zhang, X; Zhao, W; Zhou, Y; Zhu, X | 1 |
| Cheng, YM; Lai, YL; Yen, SK | 1 |
| Hassan, PA; Pandey, BN; Pandrekar, S; Priyadarsini, KI; Shetake, NG; Verma, G | 1 |
| Gao, S; Lin, J; Lin, K; Lin, Y; Xie, S; Yu, Y; Zeng, J; Zheng, M | 1 |
| Chen, G; Chen, Z; Li, X; Ma, X; Ren, X; Sun, Z; Yi, Z | 1 |
| Liu, C; Ma, X; Qian, J; Sha, D; Yuan, Y; Zhang, S | 1 |
| He, Y; Hou, X; Lv, C; Wu, L | 1 |
| Deng, H; Deng, Z; Duan, L; Fan, Q; Hong, X; Hu, W; Li, A; Li, Y; Meng, X; Tang, L; Xiao, Y; Zeng, X; Zhou, H; Zhou, W | 1 |
| Chen, C; Feng, G; He, M; Li, Y; Liu, L; Sun, D; Xu, H; Zhang, L; Zhu, C | 1 |
| Ahmadi Nasab, N; Hemmati, K; Hesaraki, S; Nezafati, N | 1 |
| Cai, X; Kong, T; Peng, S; Xiao, D; Yang, Y; Zhang, W; Zhou, R; Zhu, B | 1 |
| Du, J; Fan, J; Kang, Y; Peng, X; Sun, W; Wang, S | 1 |
| Fan, D; Heng, C; Huang, H; Hui, J; Liu, M; Wei, Y; Wen, Y; Zhang, X; Zheng, X; Zhou, X | 1 |
| Adunyah, SE; Goodwin, JS; Ingram, S; Lammers, P; Moye, C; Nangami, G; Ochieng, J; Rana, T; Sakwe, A | 1 |
| Chen, M; Chen, X; Deng, Y; Li, Y; Sang, R; Shi, J; Yang, W; Yang, Y | 1 |
| Ihara, S; Ito, A; Li, X; Ohno, T; Sogo, Y; Tsuji, NM; Wang, X; Watanabe, Y; Yamazaki, A | 1 |
| Changsheng, L; Chunyu, Z; Jiangchao, Q; Xiaoyu, M; Xiuling, D; Yi, S; Yuan, Y | 1 |
| Kojima, C; Makiura, R; Nakahira, A; Nishio, Y; Watanabe, K | 1 |
| Liu, C; Lu, X; Qian, J; Tang, W; Wu, Y; Yuan, Y | 1 |
| Gardner, B; Matousek, P; Stone, N; Vardaki, MZ | 1 |
| Ito, A; Li, X; Tsuji, NM; Wang, X; Watanabe, Y | 1 |
| Abbasi Aval, N; Arabfirouzjaei, M; Hatamian, M; Javadpour, J; Pirayesh Islamian, J; Rashidi, MR | 1 |
| Chen, Y; Shen, Y; Wang, Y; Xiao, Y; Xie, A; Yang, Y; Zhu, M | 1 |
| Denkova, A; Jansen, DR; Kolar, ZI; Krijger, GC; Zeevaart, JR | 1 |
| Hou, CH; Hou, SM; Hsueh, YS; Lin, FH; Lin, J; Wu, HC | 1 |
| Ashokan, A; Koyakutty, M; Menon, D; Nair, S | 1 |
| Chuttani, K; Gupta, KC; Jain, S; Kumar, P; Mishra, AK; Pathak, A; Patnaik, S; Swami, A; Vyas, SP | 1 |
| Di Foggia, M; Fini, M; Iafisco, M; Pietronave, S; Prat, M; Rimondini, L; Roveri, N; Varoni, E | 1 |
| Li, Y; Lin, Y; Ooi, CP | 1 |
| Bach, LG; Islam, MR; Kim, SK; Lim, KT; Vo, TS | 1 |
| Crivellin, F; Funaro, A; Horenstein, AL; Malavasi, F; Said, M | 1 |
| Ciocca, DR; Cuello-Carrión, FD; Frayssinet, P | 1 |
| Bloomfield, CD; Holbrook, NJ; Munck, A | 1 |
| Holden, JA; Rolfson, DH; Wittwer, CT | 1 |
1 review(s) available for durapatite and Neoplasms
| Article | Year |
|---|---|
Hydroxyapatite Biobased Materials for Treatment and Diagnosis of Cancer.
Topics: Drug Delivery Systems; Durapatite; Humans; Nanoparticles; Neoplasms; Porosity | 2022 |
1 trial(s) available for durapatite and Neoplasms
| Article | Year |
|---|---|
A pilot study with a therapeutic vaccine based on hydroxyapatite ceramic particles and self-antigens in cancer patients.
Topics: Adult; Aged; Animals; Antigen-Presenting Cells; Autoantigens; Cancer Vaccines; Ceramics; Durapatite; Female; Heat-Shock Proteins; Humans; Macrophages; Male; Middle Aged; Neoplasms; Phagocytosis; Pilot Projects; Rats; Rats, Sprague-Dawley; Skin | 2007 |
39 other study(ies) available for durapatite and Neoplasms
| Article | Year |
|---|---|
Surface-Fabrication of Fluorescent Hydroxyapatite for Cancer Cell Imaging and Bio-Printing Applications.
Topics: Doxorubicin; Drug Delivery Systems; Durapatite; Nanotubes; Neoplasms; Polyethyleneimine; Prospective Studies | 2022 |
Sustained delivery of gambogic acid from mesoporous rod-structure hydroxyapatite for efficient in vitro cancer therapy.
Topics: Cell Line, Tumor; Durapatite; HeLa Cells; Humans; Neoplasms; Xanthones | 2022 |
Adsorption of l-buthionine sulfoximine on Bi(III) and Eu(III) co-substituted hydroxyapatite nanocrystals for enhancing radiosensitization effects.
Topics: Adsorption; Buthionine Sulfoximine; Durapatite; Glutathione; Humans; Ions; Methionine Sulfoximine; Nanoparticles; Neoplasms | 2023 |
Hydroxyapatite nanoparticles induced calcium overload-initiated cancer cell-specific apoptosis through inhibition of PMCA and activation of calpain.
Topics: Apoptosis; Calcium; Calpain; Durapatite; Nanoparticles; Neoplasms | 2023 |
Macrophage fusion event as one prerequisite for inorganic nanoparticle-induced antitumor response.
Topics: Durapatite; Humans; Immunity; Macrophages; Nanoparticles; Neoplasms; Tumor Microenvironment | 2023 |
Morphological and fractal features of cancer cells anchored on composite layers based on magnesium-doped hydroxyapatite loaded in chitosan matrix.
Topics: Chitosan; Durapatite; Fractals; Humans; Magnesium; Neoplasms; Surface Properties | 2024 |
Application of hydroxyapatite nanoparticles in tumor-associated bone segmental defect.
Topics: Animals; Bone Regeneration; Disease Models, Animal; Durapatite; Male; Nanoparticles; Neoplasms; Porosity; Rabbits; Tissue Scaffolds; Titanium | 2019 |
Doxorubicin - chitosan - hydroxyapatite composite coatings on titanium alloy for localized cancer therapy.
Topics: Alloys; Cell Line, Tumor; Chitosan; Coated Materials, Biocompatible; Doxorubicin; Durapatite; Electrochemical Techniques; Humans; Microscopy, Electron, Scanning; Neoplasms; Porosity; Spectroscopy, Fourier Transform Infrared; Surface Properties; Titanium; X-Ray Diffraction | 2019 |
Development of surface functionalized hydroxyapatite nanoparticles for enhanced specificity towards tumor cells.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Carriers; Drug Delivery Systems; Durapatite; Folic Acid; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; KB Cells; Mice; Nanoparticles; Neoplasms | 2020 |
Surface-enhanced Raman scattering analysis of serum albumin via adsorption-exfoliation on hydroxyapatite nanoparticles for noninvasive cancers screening.
Topics: Adsorption; Durapatite; Early Detection of Cancer; Humans; Metal Nanoparticles; Nanoparticles; Neoplasms; Serum Albumin; Spectrum Analysis, Raman | 2020 |
Natural polysaccharide-incorporated hydroxyapatite as size-changeable, nuclear-targeted nanocarrier for efficient cancer therapy.
Topics: Doxorubicin; Drug Carriers; Drug Delivery Systems; Durapatite; HeLa Cells; Humans; Hyaluronic Acid; Nanoparticles; Neoplasms; Polysaccharides | 2020 |
A novel strategy for tumor therapy: targeted, PAA-functionalized nano-hydroxyapatite nanomedicine.
Topics: Acrylic Resins; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Durapatite; Folic Acid; Humans; Nanomedicine; Nanoparticles; Neoplasms | 2020 |
Mono-dispersed nano-hydroxyapatite based MRI probe with tetrahedral DNA nanostructures modification for in vitro tumor cell imaging.
Topics: DNA; Durapatite; Humans; Magnetic Resonance Imaging; Nanostructures; Neoplasms | 2020 |
Upconversion NIR-II fluorophores for mitochondria-targeted cancer imaging and photothermal therapy.
Topics: Animals; Cell Death; Durapatite; Fluorescent Dyes; Infrared Rays; Luminescence; Mice, Nude; Mitochondria; Molecular Conformation; Neoplasms; Optical Imaging; Photothermal Therapy; Polyethylene Glycols; Spectrometry, Fluorescence; Treatment Outcome | 2020 |
Conducting Polyetheretherketone Nanocomposites with an Electrophoretically Deposited Bioactive Coating for Bone Tissue Regeneration and Multimodal Therapeutic Applications.
Topics: Animals; Anti-Bacterial Agents; Benzophenones; Bone Regeneration; Cell Line, Tumor; Cell Proliferation; Coated Materials, Biocompatible; Durapatite; Electric Conductivity; Escherichia coli; Female; Graphite; Humans; Infrared Rays; Ketones; Mesenchymal Stem Cells; Mice, Inbred BALB C; Nanocomposites; Neoplasms; Osseointegration; Photothermal Therapy; Polyethylene Glycols; Polymers; Quaternary Ammonium Compounds; Staphylococcus aureus; Xenograft Model Antitumor Assays | 2020 |
Topics: Antineoplastic Agents; Chitosan; Curcumin; Drug Carriers; Durapatite; Nanoparticles; Neoplasms; Spectroscopy, Fourier Transform Infrared | 2021 |
Aptamer-mediated synthesis of multifunctional nano-hydroxyapatite for active tumour bioimaging and treatment.
Topics: Animals; Antineoplastic Agents; Aptamers, Nucleotide; Cell Line, Tumor; Doxorubicin; Drug Carriers; Durapatite; Female; Humans; Magnetic Resonance Imaging; Mice; Mice, Nude; Microscopy, Electron, Transmission; Nanoparticles; Neoplasms; Oligodeoxyribonucleotides; Particle Size | 2021 |
Biodegradable Drug-Loaded Hydroxyapatite Nanotherapeutic Agent for Targeted Drug Release in Tumors.
Topics: Animals; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Durapatite; Folic Acid; Mice; Neoplasms | 2018 |
Surface grafting of rare-earth ions doped hydroxyapatite nanorods (HAp:Ln(Eu/Tb)) with hydrophilic copolymers based on ligand exchange reaction: Biological imaging and cancer treatment.
Topics: A549 Cells; Cell Survival; Diagnostic Imaging; Differential Thermal Analysis; Drug Liberation; Durapatite; Humans; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Ions; Ligands; Metals, Rare Earth; Nanotubes; Neoplasms; Polymers; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Surface Properties; Thermogravimetry | 2018 |
Extracellular histones are the ligands for the uptake of exosomes and hydroxyapatite-nanoparticles by tumor cells via syndecan-4.
Topics: alpha-2-HS-Glycoprotein; Cell Line, Tumor; Cell Membrane; Durapatite; Endocytosis; Exosomes; Extracellular Space; Histones; Humans; Ligands; Microscopy, Confocal; Nanoparticles; Neoplasms; PC-3 Cells; RNA Interference; Syndecan-4 | 2018 |
HAp@GO drug delivery vehicle with dual-stimuli-triggered drug release property and efficient synergistic therapy function against cancer.
Topics: Animals; Cell Death; Cell Line; Doxorubicin; Drug Delivery Systems; Drug Liberation; Drug Synergism; Durapatite; Endocytosis; Graphite; Humans; Hyperthermia, Induced; Materials Testing; Models, Biological; Neoplasms; Phototherapy; Rabbits; Spectrophotometry, Ultraviolet | 2019 |
Rod-Scale Design Strategies for Immune-Targeted Delivery System toward Cancer Immunotherapy.
Topics: Adsorption; Animals; Antigens, Neoplasm; Antineoplastic Agents; Biocompatible Materials; Cells, Cultured; Drug Delivery Systems; Durapatite; Female; Immunotherapy; Injections, Subcutaneous; Lymph Nodes; Mice; Mice, Inbred C57BL; Neoplasms; Optical Imaging; Ovalbumin; Particle Size; Surface Properties | 2019 |
Polyglutamic acid-coordinated assembly of hydroxyapatite nanoparticles for synergistic tumor-specific therapy.
Topics: Animals; Calcium; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Carriers; Drug Liberation; Drug Synergism; Durapatite; Female; Humans; Hydrogen-Ion Concentration; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Nanoparticles; Neoplasms; Polyglutamic Acid; Solubility | 2019 |
Paclitaxel-loaded hydroxyapatite/collagen hybrid gels as drug delivery systems for metastatic cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Survival; Collagen; Drug Carriers; Durapatite; Gels; Humans; Neoplasms; Paclitaxel | 2013 |
Differential cytotoxicity and particle action of hydroxyapatite nanoparticles in human cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Calcium; Caspase 3; Cell Line, Tumor; Cell Proliferation; Durapatite; Humans; Nanoparticles; Neoplasms; Reactive Oxygen Species | 2014 |
Studying the distribution of deep Raman spectroscopy signals using liquid tissue phantoms with varying optical properties.
Topics: Breast; Durapatite; Female; Humans; Light; Lipids; Male; Neoplasms; Phantoms, Imaging; Prostate; Spectrum Analysis, Raman | 2015 |
Rod-shaped and fluorine-substituted hydroxyapatite free of molecular immunopotentiators stimulates anti-cancer immunity in vivo.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Durapatite; Fluorine; Immunity; Immunotherapy; Mice; Nanoparticles; Neoplasms; NIH 3T3 Cells | 2016 |
Doxorubicin loaded large-pore mesoporous hydroxyapatite coated superparamagnetic Fe3O4 nanoparticles for cancer treatment.
Topics: Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Durapatite; Ferrosoferric Oxide; Humans; Hydrogen-Ion Concentration; Magnetite Nanoparticles; Neoplasms; Porosity | 2016 |
RGO/AuNR/HA-5FU nanocomposite with multi-stage release behavior and efficient antitumor activity for synergistic therapy.
Topics: Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Delivery Systems; Durapatite; Fluorouracil; Gold; Graphite; HeLa Cells; Humans; Nanocomposites; Nanotubes; Neoplasms; Oxidation-Reduction; Oxides; Phototherapy | 2017 |
Hydroxyapatite chemisorption of N,N',N'-trimethylenephosphonate-poly(ethyleneimine) (PEI-MP) combined with Sn2+ or Sn4+.
Topics: Adsorption; Bone and Bones; Durapatite; Humans; Hydrogen-Ion Concentration; Ligands; Neoplasms; Organophosphonates; Organotin Compounds; Polyethyleneimine; Radionuclide Imaging; Radiopharmaceuticals; Spectrophotometry; Surface Properties; Temperature; Tin | 2009 |
The in vivo performance of biomagnetic hydroxyapatite nanoparticles in cancer hyperthermia therapy.
Topics: Animals; Cell Line, Tumor; Durapatite; Hyperthermia, Induced; Magnetics; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms | 2009 |
A molecular receptor targeted, hydroxyapatite nanocrystal based multi-modal contrast agent.
Topics: Animals; Carrier Proteins; Cell Line; Contrast Media; Crystallography, X-Ray; Durapatite; Endothelial Cells; Flow Cytometry; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Infrared Rays; Magnetic Resonance Spectroscopy; Magnetics; Mice; Microscopy, Fluorescence; Molecular Imaging; Nanoparticles; Neoplasms; Particle Size; Polyethyleneimine; Receptors, Cell Surface; Spectrometry, Fluorescence; Umbilical Veins; Vibration | 2010 |
Efficient tumor targeting by polysaccharide decked polyethylenimine based nanocomposites.
Topics: DNA; Drug Delivery Systems; Durapatite; Gene Targeting; HeLa Cells; Humans; Kidney; Nanostructures; Neoplasms; Polyethyleneimine; Polysaccharides; Transfection | 2009 |
Conjugation of hydroxyapatite nanocrystals with human immunoglobulin G for nanomedical applications.
Topics: Adsorption; Antineoplastic Agents; Binding Sites; Blotting, Western; Drug Carriers; Durapatite; Enzyme-Linked Immunosorbent Assay; Humans; Immunoconjugates; Immunoglobulin G; Molecular Targeted Therapy; Nanomedicine; Nanoparticles; Neoplasms; Particle Size; Protein Binding; Protein Structure, Secondary; Spectrum Analysis; Static Electricity; Surface Properties | 2012 |
5-Fluorouracil encapsulated HA/PLGA composite microspheres for cancer therapy.
Topics: Antimetabolites, Antineoplastic; Durapatite; Fluorouracil; Lactic Acid; Microscopy, Electron, Scanning; Neoplasms; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Viscosity | 2012 |
Poly(allyl methacrylate) functionalized hydroxyapatite nanocrystals via the combination of surface-initiated RAFT polymerization and thiol-ene protocol: a potential anticancer drug nanocarrier.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; Cisplatin; Drug Carriers; Durapatite; HeLa Cells; Humans; Methacrylates; Nanoparticles; Neoplasms; Polymerization; Polymethacrylic Acids; Sulfhydryl Compounds | 2013 |
Design and scaleup of downstream processing of monoclonal antibodies for cancer therapy: from research to clinical proof of principle.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Chromatography, Affinity; Chromatography, Gel; Chromatography, High Pressure Liquid; Durapatite; Equipment Reuse; Humans; Mice; Neoplasms; Quality Control; Staphylococcal Protein A | 2003 |
Characteristics, stability and regulation of glucocorticoid-receptor complexes in normal and neoplastic cells as studied with a new mini-column technique.
Topics: Acute Disease; Animals; Cell Line; DEAE-Cellulose; DNA; Durapatite; Glucocorticoids; Humans; Hydroxyapatites; Kinetics; Neoplasms; Rats; Receptors, Glucocorticoid; Receptors, Steroid | 1984 |
The distribution of immunoreactive topoisomerase II Protein in human tissues and neoplasms.
Topics: Blotting, Western; Cell Cycle; Cell Nucleus; Chromatography; DNA Topoisomerases, Type II; Durapatite; Electrophoresis, Polyacrylamide Gel; Female; HeLa Cells; Humans; Hydroxyapatites; Immune Sera; Liver; Molecular Weight; Neoplasms; Placenta; Pregnancy; Recombinant Proteins | 1992 |